The authors of this review noted a decrease in mortality over time, but stated that treatment of brain arteriovenous malformations remained associated with considerable risks and incomplete efficacy. They recommended that randomised controlled trials should be conducted to compare different treatments for the condition. This recommendation appears appropriate given that the review located only observational studies (which cannot determine causality).
To assess rates of mortality, long-term risk of haemorrhage, complications and successful obliteration of brain arteriovenous malformations (AVM) after intervention and to assess determinants of these outcomes
Searching
PubMed and EMBASE were searched up to March 2011 using search terms documented in the report. Six relevant journals were handsearched from January 2000 to March 2011.
Study selection
Eligible studies needed to report on at least 15 consecutive patients of any age who underwent brain AVM treatment. Follow-up duration needed to be noted as did death and intracranial haemorrhage after treatment. Articles in languages other than English, French, German, Italian and Spanish were excluded. Studies that described other intracranial vascular malformations were excluded. Studies where 20% or more of patients were lost to follow-up and studies where 5% or more were not treated were excluded.
The three treatments investigated were microsurgery, stereotactic radiosurgery (SRS) and embolisation. The primary outcome was all-cause case fatality during treatment and follow-up. The secondary outcome was intracranial haemorrhage beyond 30 days of treatment. Tertiary outcomes were treatment complications and successful obliteration of brain AVMs.
Two authors were involved in the selection of studies for the review. Discrepancies were resolved by consensus.
Assessment of study quality
High-quality studies were defined as those with either a prospective study design or an independent outcome measure.
Two reviewers were involved in the assessment. Disagreements were resolved by consensus.
Data extraction
Where multiple publications were produced from the same cohort, the authors included the largest cohort.
Two authors extracted data for the review. Discrepancies were resolved by consensus.
Methods of synthesis
The authors calculated case fatality and haemorrhage rates per 100 person-years for all cohorts and for each treatment modality separately with the number of outcomes and the number of person-years for each study as parameters in regression models. Sensitivity analyses were conducted to investigate the impact of study quality on overall case fatality and haemorrhage rates. Statistical heterogeneity was assessed for case fatality and haemorrhage rates in all cohorts and in the three treatment modalities separately. Regression analysis was used to investigate the associations of study characteristics on the occurrence of complications and on the proportion of patients in whom successful obliteration was achieved after each of the three treatment modalities.
